Skip to main content
. 2021 Jan 30;7(1):e05926. doi: 10.1016/j.heliyon.2021.e05926

Table 2.

Study population and method of data collection.

Study Participant Sample size Data collection method
Pregnant mothers – prim gravida & multiple 6 SSI
Non-pregnant women with/without children 10 SSI
Women enrolled in maternal immunization trials and who previously had a child with Group B streptococcus (survived or died) 10 SSI
Husbands/partners of pregnant women 1 × 6 participants FGD
Mothers of pregnant women 1 × 6 participants FGD
Antenatal and maternity staff from community and tertiary hospitals 7 KII
Other maternity healthcare providers such as doulas, midwives, breastfeeding consultants 5 SSI
Community leaders 5 KII